Iveda Solutions, Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. FINANCIAL STATEMENTS
| ITEM 1. | FINANCIAL STATEMENTS. |
|---|
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| (UNAUDITED) | ||
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash and Cash Equivalents | $5,632,622 | $5,156,252 |
| Restricted Cash | 62,488 | 63,694 |
| Accounts Receivable, Net | 745,311 | 256,699 |
| Deferred Cost of Goods | 120,185 | 116,951 |
| Inventory, Net | 247,974 | 235,958 |
| Other Current Assets | 717,366 | 326,005 |
| Total Current Assets | 7,525,946 | 6,155,559 |
| Property and Equipment, Net | 41,147 | 47,093 |
| Right of Use Asset, Net | 138,405 | 148,943 |
| Other Assets | 152,993 | 76,195 |
| Total Assets | $7,858,491 | $6,427,790 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts and Other Payables | $1,491,813 | $938,560 |
| Short Term Debt | - | 159,500 |
| Current Portion of Long-Term Debt | 125,184 | 127,600 |
| Current Portion of Lease Liability | 42,898 | 41,632 |
| Total Current Liabilities | 1,659,895 | 1,267,292 |
| Long Term Debt | 229,503 | 265,832 |
| Long Term Lease Liability, Net of Current Portion | 104,834 | 114,904 |
| Total Liabilities | 1,994,232 | 1,648,028 |
| STOCKHOLDERS’ EQUITY | ||
| Preferred Stock, $0.00001 par value; 12,500,000 shares authorized, no preferred shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | - | - |
| Common Stock, $0.00001 par value; 300,000,000 shares authorized; 11,594,027 and 5,879,741 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 117 | 59 |
| Additional Paid-In Capital | 63,040,326 | 61,403,700 |
| Accumulated Other Comprehensive Loss | (268,524) | (249,168) |
| Accumulated Deficit | (56,907,660) | (56,374,829) |
| Total Stockholders’ Equity | 5,864,259 | 4,779,762 |
| Total Liabilities and Stockholders’ Equity | $7,858,491 | $6,427,790 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| For the Three Months ended March 31, 2026 | For the Three Months ended March 31, 2025 | |
|---|---|---|
| REVENUE | ||
| Equipment Sales | $1,419,340 | $1,408,732 |
| Service Revenue | 74,834 | 65,844 |
| TOTAL REVENUE | 1,494,174 | 1,474,576 |
| COST OF REVENUE | 998,966 | 1,186,365 |
| GROSS PROFIT | 495,208 | 288,211 |
| OPERATING EXPENSES | ||
| General & Administrative | 1,030,910 | 1,090,770 |
| Research & Development | 30,000 | 33,000 |
| Total Operating Expenses | 1,060,910 | 1,123,770 |
| LOSS FROM OPERATIONS | (565,702) | (835,559) |
| OTHER INCOME (EXPENSE) | ||
| Miscellaneous Income (Expense) | 6,141 | 32,422 |
| Interest Income | 32,336 | 15,261 |
| Interest Expense | (5,606) | (5,796) |
| Total Other Income (Expense), Net | 32,871 | 41,887 |
| NET LOSS | $(532,831) | $(793,672) |
| BASIC AND DILUTED LOSS PER SHARE | $(0.06) | $(0.28) |
| WEIGHTED AVERAGE SHARES | 8,927,360 | 2,808,071 |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
| For the Three Months ended March 31, 2026 | For the Three Months ended March 31, 2025 | |
|---|---|---|
| Net Loss | $(532,831) | $(793,672) |
| Other Comprehensive Loss | ||
| Change in Equity Adjustment from Foreign Currency Translation, Net of Tax | (19,356) | (10,880) |
| Comprehensive Loss | $(552,187) | $(804,552) |
See accompanying Notes to Unaudited Condensed Consolidated Financial Statements*.***
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Accumulated | ||||||
|---|---|---|---|---|---|---|
| Common · Additional · Other · Total | ||||||
| Common | Stock | Paid-in- | Accumulated | Comprehensive | Stockholders’ | |
| Stock | Amount | Capital | Deficit | (Loss) | Equity | |
| BALANCE AT December 31, 2024 | 2,808,071 | $28 | $55,962,337 | $(53,176,717) | $(280,209) | $2,505,439 |
| Net Loss | - | - | - | (793,672) | - | (793,672) |
| Comprehensive Loss | - | - | - | - | (10,880) | (10,880) |
| BALANCE AT March 31, 2025 | 2,808,071 | $28 | $55,962,337 | $(53,970,389) | $(291,089) | $1,700,887 |
| BALANCE AT December 31, 2025 | 5,879,741 | $59 | $61,403,700 | $(56,374,829) | $(249,168) | $4,779,762 |
| Sale of Common Stock | 5,714,286 | 58 | 1,624,626 | 1,624,684 | ||
| Stock Option Compensation | 12,000 | 12,000 | ||||
| Net Loss | (532,831) | (532,831) | ||||
| Comprehensive Loss | (19,356) | (19,356) | ||||
| BALANCE AT March 31, 2026 | 11,594,027 | $117 | $63,040,326 | $(56,907,660) | $(268,524) | $5,864,259 |
See accompanying Notes to Unaudited Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| March 31, 2026 | March 31, 2025 | |
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net Loss | $(532,831) | $(793,672) |
| Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities | ||
| Depreciation and Amortization | 5,872 | 7,285 |
| Stock Compensation Expense | 12,000 | - |
| Increase in allowance for uncollectible accounts | 20,000 | |
| Changes in operating assets and liabilities | ||
| Accounts Receivable | (508,612) | 457,885 |
| Inventory | (12,016) | (69,508) |
| Deferred Cost of Goods | (3,234) | 147,920 |
| Right of Use Asset | 10,538 | 3,314 |
| Other Current Assets | (386,488) | 138,253 |
| Other Assets | (76,798) | 12,704 |
| Increase in Accounts and Other Payables | 553,253 | (29,010) |
| Lease Liability | (8,804) | (1,137) |
| Net Cash Used in Operating Activities | (927,120) | (125,966) |
| CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Purchase of Property and Equipment | - | 109 |
| Net Cash Used in Investing Activities | - | 109 |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Payments on Short-Term Debt, net | (159,500) | - |
| Proceeds from Short-Term Debt | - | 37,909 |
| Proceeds from (Payments on) Long-Term Debt | (38,745) | (37,070) |
| Common Stock Issued, Net of Cost of Financing | 1,624,684 | - |
| Net Cash Provided by Financing Activities | 1,426,439 | 839 |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH | (24,155) | (14,194) |
| NET DECREASE IN CASH, RESTRICTED CASH AND CASH EQUIVALENTS | 475,164 | (139,212) |
| Cash, Restricted Cash and Cash Equivalents- Beginning of Period | 5,219,946 | 2,658,300 |
| CASH, RESTRICTED CASH AND CASH EQUIVALENTS - END OF PERIOD | $5,695,110 | $2,519,088 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - CONTINUED
| March 31, 2026 · March 31, 2025 | |||
|---|---|---|---|
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |||
| Interest Paid | $2,525 | $6,063 | |
| Income Tax Paid | $ | - | $476 |
| SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES | |||
| Present Value of Right of Use Asset and Lease Obligations on New Lease | $ | - | $182,668 |
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Iveda Solutions, Inc. (“Iveda”, or the “Company”) was incorporated in Nevada as Charmed Homes, Inc. in June 2006. On October 15, 2009, IntelaSight, d/b/a Iveda, a Washington corporation, became a wholly owned subsidiary of the Company. In December 2010, IntelaSight merged with and into the Company and the Company became the surviving company. Iveda offered the first cloud hosting of streaming and recorded video from security cameras for its customers and real-time remote surveillance service utilizing intervention specialists to watch our customers’ cameras in real time, 24/7. Iveda offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide.
Consolidation
Effective April 30, 2011, we completed our acquisition of Sole Vision Technologies (fka MEGAsys and dba Iveda Taiwan), a company based in Taiwan. We consolidate our financial statements with the financial statements of Iveda Taiwan. All intercompany balances and transactions have been eliminated in consolidation.
Liquidity
The Company recorded a net loss of $0.5 million and used cash in operations of $0.9 million during the period ended March 31, 2026. During 2025, and subsequently, the Company took significant steps to raise capital to fund operations, and to reduce its historical operating losses. In accordance with Accounting Standards Codification (“ASC”) 205-40, Going Concern, the Company’s management has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the accompanying financial statements were issued. As of the issuance date of these financial statements, management expects that the Company’s cash of $5.7 million at March 31, 2026, will be sufficient to fund the Company’s current operating plan for at least twelve months from the date of issuance of these financial statements.
Management’s assessment whether there is sufficient cash on hand, together with expected capital raises, to assure operations for a period of at least twelve months from the date these financial statements are issued, is based on conditions that are known and reasonably knowable to management, considering various scenarios, projections, and estimates and certain key assumptions. These assumptions include, among other factors, management’s ability to increase operating efficiencies, raise additional capital, and the expected timing and nature of the Company’s forecasted cash expenditures.
Historically, the Company has financed its operations through public and private sales of common stock, credit lines from financial institutions, and cash generated from operations. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. On an ongoing basis, we evaluate our estimates, including those related to accounts receivable, deferred cost of revenue, share-based compensation, deferred income taxes, provisions for losses, and inventory reserve, among other items.
Revenue and Expense Recognition
The Company applies the provisions of Accounting Standards Codification (ASC) 606-10,Revenue from Contracts with Customers, and all related appropriate guidance. The Company recognizes revenue under the core principle to depict the transfer of control to its customers in an amount reflecting the consideration to which it expects to be entitled. In order to achieve that core principle, the Company applies the following five-step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.
The Company considers customer purchase orders, which in some cases are governed by master sales agreements, to be the contracts with the customer. In situations where sales are to a distributor, the Company had concluded its contracts are with the distributor as the Company holds a contract bearing enforceable rights and obligations only with the distributor. As part of its consideration for the contract, the Company evaluates certain factors including the customers’ ability to pay (or credit risk). For each contract, the Company considers the promise to transfer products, each of which is distinct, to be the identified performance obligations. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which it expects to be entitled. As the Company’s standard payment terms are less than one year, it has elected the practical expedient under ASC 606-10-32-18 to not assess whether a contract has a significant financing component. The Company allocates the transaction price to each distinct product based on its relative standalone selling price. The product price as specified on the purchase order is considered the standalone selling price as it is an observable input which depicts the price as if sold to a similar customer in similar circumstances. Revenue is recognized when control of the product is transferred to the customer (i.e., when the Company’s performance obligations is satisfied), which typically occurs at shipment unless installation is required as with certain of our Taiwan sales – see below. Further in determining whether control has been transferred, the Company considers if there is a present right to payment and legal title, along with risks and rewards of ownership having transferred to the customer. Customers do not have a right to return the product other than for warranty reasons for which they would only receive repair services or replacement product. The Company has also elected the practical expedient under ASC 340-40-25-4 to expense commissions for product sales when incurred as the amortization period of the commission asset the Company would have otherwise recognized is less than one year.
The Company sells its products and services primarily to municipalities and commercial customers in the following manner:
| ● | The majority of Iveda Taiwan sales are project sales to Taiwan customers and are made direct to the end customer (typically a municipality or a commercial customer) through its sales force, which is composed of its employees. Revenue is recorded when the equipment is shipped to the end customer unless the contract requires the inventory to be installed before it can be billed and charged for service when installation or maintenance work is performed. If inventory is shipped to the customer before it is installed the inventory is reclassified to Deferred Cost of Goods. |
Revenue for product and software sales without installation is recorded when the product and/or software has been shipped to the customer. Revenue from fixed-price equipment installation contracts, if any, is recognized as the contracts allow for invoicing at various milestones.
General and administrative costs are charged to expense as incurred. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability may result in revisions to costs and income and are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, contract penalty provisions, claims, change orders, and settlements are accounted for as changes in estimates in the current period. Profit incentives are included in revenue when their realization is deemed earned by the contract.
| ● | Iveda US hardware sales are to domestic and international independent distributors or integrators who purchase products from the Company at a wholesale price and sell to the end user (typically municipalities or a commercial customer) at a retail price. The Company will maintain product inventory and ship to the distributor or integrator or product is drop shipped from the manufacturer at the request of the Company to the distributor or integrator, and the Company at all times maintains the obligation to pay vendors and all related risks and rewards of ownership of customer receivables. Accordingly, upon application of steps one through five above, revenue is recorded when the product is shipped to the distributor or as directed by the distributor consistent with the terms of the distribution agreement. |
| ● | Iveda US also sells a one time software license to customers that allows them to activate software embedded in the purchased hardware. The software revenues are recorded as the license is delivered. |
| ● | Iveda US also sells hardware and software warranty and maintenance for an annual fee that are paid yearly. The revenues are recorded annually, if the revenue is a material amount it will be recorded as deferred revenue and amortized on a straight-line basis over the respective time period. |
The Company sells and installs video surveillance systems comprised of various components of hardware and software.
The following table presents our net sales by revenue source and the period over period percentage change, for the period presented:
| For the three months ended March 31, 2026 | For three months ended March 31, 2025 | |
|---|---|---|
| Net Sales Source | ||
| Commercial Enterprises | $503,430 | $666,394 |
| Distributors | $23,482 | $178,166 |
| Municipalities | $18,724 | $18,131 |
| Taiwan Government | $948,538 | $611,885 |
| Net Sales Source | $1,494,174 | $1,474,576 |
The Company sells and installs video surveillance systems comprised of various components of hardware and software.
Concentrations
Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.
Substantially all cash is deposited in three financial institutions, two in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (Central Deposit Insurance Corporation) with maximum coverage of 3 million New Taiwan Dollar (NTD). At times, amounts on deposit in Taiwan may be in excess of the CDIC Insurance limit.
Revenue from two customers out of approximately 74 total customers represented approximately 79% of total revenue for the three months ended March 31, 2026. These specific customers were 1) National Chung Shan Institute of Science and Technology with 63%, 2) Chunghwa Telecom with 16% (both Taiwan companies). Revenue from two customers out of approximately 70 total customers represented approximately 58% of total revenue for the three months ended March 31, 2025. These specific customers were 1) National Chung Shan Institute of Science and Technology with 41% and 2) Chunghwa Telecom with 17% (both Taiwan companies).
No other customers represented greater than 10% of total revenues the three months ended March 31, 2026 and 2025.
84% of the total accounts receivable at March 31, 2026 was from one customer out of a total of 32 customer accounts receivable accounts. This specific customers was National Chung Shan Institute of Science and Technology. Our accounts receivables are unsecured, and we are at risk to the extent such amounts become uncollectible. Although we perform periodic evaluations of our customers’ credit and financial condition, we do not require collateral in exchange for our products and services provided on credit. These customers are longtime customers, and we don’t expect any problem with the collectability of these accounts receivable.
Cash and Cash Equivalents
For purposes of the statement of cash flows, we consider all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents.
The Company’s consolidated financial statements include the results of operations and financial position of its subsidiary located in Taiwan. The subsidiary’s functional currency is the Taiwan New Dollar (TWD). For consolidation purposes, the subsidiary’s financial statements are translated into US Dollars (USD) using the following methods: Assets and liabilities are translated using the exchange rate at the balance sheet date. Income statement items are translated using the average exchange rate for the period. Exchange rate fluctuations between TWD and USD result in gains or losses that are included in Other Comprehensive Income (Loss) until they are realized. The Company had approximately $1 million and $1.4 million of its cash and cash equivalents in Taiwan New Dollars at March 31, 2026 and December 31, 2025, respectively.
Accounts Receivable
We provide an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. For our U.S.-based segment, receivables past due more than 120 days, if any, are considered delinquent. For our Taiwan-based segment, receivables over one year, if any, are considered delinquent. Delinquent receivables are written off based on individual credit valuation and specific circumstances of the customer. There was no reserve necessary at March 31, 2026 or December 31, 2025.
Warrant Instruments
The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the instruments’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the instruments are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the instruments meet all of the requirements for equity classification under ASC 815, including whether the instruments are indexed to the Company’s own Common Stock and whether the instrument holders could potentially require net cash settlement in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and, for liability-classified warrants, at each reporting period end date while the warrants are outstanding.
Restricted Cash
Restricted cash represents time deposits on account to secure short-term bank loans in our Taiwan-based segment.
Stock-Based Compensation
The Company periodically issues stock, stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, Compensation-Stock Compensation whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods. We recognized $12,000 and $0 of stock-based compensation expense for the three months ended March 31, 2026 and 2025, respectively, related to the amortization of stock options.
Fair Value of Financial Instruments
The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. Accounting Standards Codification Section 820 defines the following levels of subjectivity associated with the inputs:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.
Level 3—Unobservable inputs in which there is little or no market data for the asset or liability which requires the Company to develop its own assumptions.
Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to us as of March 31, 2026 and 2025. The respective carrying values of certain on-balance-sheet financial instruments approximate their fair values. These financial instruments include cash, accounts receivable, accounts payable, accrued expenses, and amounts due to related parties. Fair values were assumed to approximate carrying values for these financial instruments because they are short-term in nature and their carrying amounts approximate their fair values or because they are receivable or payable on demand. The carrying values of financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.
New Accounting Standards
In November 2024, FASB issued ASU 2024-03 Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40) Disaggregation of Income Statement Expenses. The guidance in ASU 2024-03 requires public business entities to disclose in the notes to the financial statements, among other things, specific information about certain costs and expenses including purchases of inventory; employee compensation; and depreciation and amortization expense for each caption on the income statement where such expenses are included. The update is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments may be applied prospectively to reporting periods after the effective date or retrospectively to all periods presented in the financial statements. We are currently evaluating the provisions of this guidance and assessing the potential impact on our financial statement disclosures.
Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.
NOTE 2 Accounts and Other Payables
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| Accounts Payable | $876,327 | $459,308 |
| Accrued Expenses | 302,331 | 479,057 |
| Deferred Revenue and Customer Deposits | 313,155 | 195 |
| Accounts and Other Payables | $1,491,813 | $938,560 |
NOTE 3 SHORT-TERM AND LONG-TERM DEBT
The short-term debt balances were as follows:
| March 31, 2026 · December 31, 2025 | |||
|---|---|---|---|
| Loan from HuaNam Bank at 3.45% interest rate per annum. Due in July 2026. | - | 159,500 | |
| Balance at end of period | $ | - | $159,500 |
The Company repaid the outstanding loan balance during the period ended March 31, 2026, and there are no further obligations due to this bank.
The Long-term debt balances were as follows:
| Loans from Shanghai Commercial Bank with interest rates 2.1% per annum due January 2029 (1) | $354,687 | $393,432 |
|---|---|---|
| Current Portion of Long-term debt | (125,184) | (127,600) |
| Balance at end of period | $229,503 | $265,832 |
On January 24, 2024, the Company received a facility notice from Shanghai Commercial Bank, granting a revolving loan facility totaling up to TWD 10,000,000 (approximately $300,000 USD) and term loan facility amounting of TWD 20,000,000 (approximately ($600,000 USD). The term for the revolving loan is 1 year and for the term loan is 5 years. The 5 year term loan requires monthly payments including interest and principal, and the revolving loan requires a full principal repayment at the maturity date. The guarantors of this loan are Mr. Siu and Mr. Cheung, who are both part of Iveda Taiwan’s management team.
As of March 31, 2026, and December 31, 2025, there was $62,488 and $63,694, respectively, of restricted cash pledged as security for the Shanghai Commercial Bank long term loan.
NOTE 4 PREFERRED STOCK
We are currently authorized to issue up to 12,500,000 shares of preferred stock, par value $0.00001 per share,1,250,000 shares of which are designated as Series A Preferred Stock and 500 shares of which are designated as Series B Preferred Stock. Our Articles of Incorporation authorize the issuance of shares of preferred stock with designations, rights, and preferences determined from time to time by our Board of Directors. Accordingly, our Board of Directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting, or other rights which could adversely affect the voting power or other rights of the stockholders of our common stock. In the event of issuance, the preferred stock could be utilized, under certain circumstances, as a method of discouraging, delaying, or preventing a change in control of our company.
NOTE 5 EQUITY
Common Stock
We are authorized to issue up to 300,000,000 shares of common stock, par value $0.00001 per share. We effectuated a reverse stock split on September 17, 2024 of 1 for 8 shares of common stock. All share values within this report have been retroactively adjusted to the post reverse split values. All outstanding shares of our common stock are of the same class and have equal rights and attributes. The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of the stockholders of our company. Our common stock does not have cumulative voting rights. Persons who hold a majority of the outstanding shares of our common stock entitled to vote on the election of directors can elect all of the directors who are eligible for election. Holders of our common stock are entitled to share equally in dividends, if any, as may be declared from time to time by our Board of Directors. In the event of liquidation, dissolution, or winding up of our company, subject to the preferential liquidation rights of any series of preferred stock that we may from time to time designate, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of all liabilities and preferential liquidation rights. Holders of our common stock have no conversion, exchange, sinking fund, redemption, or appraisal rights (other than such as may be determined by the Board of Directors in its sole discretion) and have no preemptive rights to subscribe for any of our securities.
On February 11, 2026, Iveda Solutions, Inc., a Delaware corporation (the “Company”) consummated a public offering (the “Offering”) for aggregate gross proceeds of approximately $2 million before deducting placement agent fees and other offering expenses payable by the Company. Net proceeds to the Company after the payment of all costs was $1.6 Million. The Offering included (i)5,259,999 shares (the “Shares”) of the Company’s common stock, par value $0.00001 per share (“Common Stock”) at an offering price of $0.35 per share of Common Stock, and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 454,287 shares of Common Stock, at an offering price of $0.3499 per Pre-Funded Warrant and (iii) accompanying series X warrants (the “Series X Warrants”) to purchase up to 11,428,572 shares of Common Stock.and accompanying Series X Warrant.
The Pre-Funded Warrants are immediately exercisable subject to certain ownership limitations, have an exercise price of $0.0001 per share, and may be exercised at any time until all of the Pre-Funded Warrants have been exercised in full. The Series X Warrants are exercisable at a price of $0.35 per share, are exercisable from and after the date of their issuance and expire on the second (2)-year anniversary of the original issuance date. All of the pre-funded warrants were exercised during the period ended March 31, 2026 resulting in an aggregate issuance of 5,714,286 shares of common stock from the offering.
In addition, the Company issuedtwo year placement agent warrants to purchase 400,000 shares of common stock at an exercise price of $0.4375 per share.
NOTE 6 STOCK OPTION PLANS
Stock Options
On January 18, 2010, we adopted the 2010 Stock Option Plan (the “2010 Option Plan”), which allows the Board to grant options to purchase up to 15,625 shares of common stock to directors, officers, key employees, and service providers of our company. In 2011, the 2010 Option Plan was amended to increase the number of shares issuable under the 2010 Option Plan to 375,000 shares. In 2012, 2010 Option Plan was again amended to increase the number of shares issuable under the 2010 Option Plan to 203,125 shares. The shares issuable pursuant to the 2010 Option Plan are registered with the SEC under Forms S-8 filed on February 4, 2010 (No. 333- 164691), June 24, 2011 (No. 333-175143), and December 4, 2013 (No. 333-192655). The 2010 Option Plan expired on January 18, 2020. As of March 31, 2026 there were 14,308 options outstanding under the 2010 Option Plan and as of December 31, 2025 there were 14,778 options outstanding under the 2010 Option Plan.
On December 15, 2020, we adopted the Iveda Solutions, Inc. 2020 Plan (the “2020 Plan”). The 2020 Plan had a maximum of 156,250 shares authorized with similar terms and conditions to the 2010 Option Plan. The shares issuable pursuant to the 2020 Option Plan are registered with the SEC under Forms S-8 filed on October 7, 2022 (No. 333- 267792). In 2025 and 2024, the 2020 Option Plan was amended to increase the number of shares issuable under the 2020 Option Plan to 1,156,250 and 656,250 shares, respectively. As of March 31, 2026 there were 717,834 options outstanding under the 2020 Option Plan. As of December 31, 2025 there were 720,959 options outstanding under the 2020 Option Plan.
As of March 31, 2026 and December 31, 2025, there were 732,142 and 735,737 options outstanding, respectively, under all the option plans.
Stock options may be granted as either incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or as options not qualified under Section 422 of the Code. All options are issued with an exercise price at or above the fair market value of the common stock on the date of the grant as determined by our Board of Directors. Incentive stock option plan awards of restricted stock are intended to qualify as deductible performance-based compensation under Section 162(m) of the Code. Incentive Stock Option awards of unrestricted stock are not designed to be deductible to us under Section 162(m). Under the plans, stock options will terminate on the tenth anniversary date of the grant or earlier if provided in the grant.
We have also granted non-qualified stock options to employees and contractors. All non-qualified options are generally issued with an exercise price no less than the fair value of the common stock on the date of the grant as determined by our Board of Directors. Options may be exercised up to ten years following the date of the grant, with vesting schedules determined by us upon grant. Vesting schedules vary by grant, with some fully vesting immediately upon grant to others that ratably vest over a period of time up to four years. Standard vested options may be exercised up to three months following date of termination of the relationship unless alternate terms are specified at grant. The fair values of options are determined using the Black-Scholes option-pricing model. The estimated fair value of options is recognized as expense on the straight-line basis over the options’ vesting periods.. During the three months ended March 31, 2026, the Company repriced 535,000 which resulted in an incremental compensation cost of $12,000 that was recorded during the period.
Stock option transactions during three months ended March 31, 2026 were as follows:
| Shares | Weighted- Average Exercise Price | |
|---|---|---|
| Outstanding at Beginning of Period | 735,737 | 5.50 |
| Granted | - | - |
| Exercised | - | - |
| Forfeited or Cancelled | (3,595) | 6.90 |
| Outstanding at End of Period | 732,142 | 5.11 |
| Options Exercisable at Period-End | 730,267 | $5.12 |
During the three months ended March 31, 2026 and 2025 the Company recognized $12,000 and $0 of compensation cost relating to the vesting of options.
| Options Outstanding · Options Exercisable | |||||
|---|---|---|---|---|---|
| Range of Exercise Prices | Number Outstanding at March 31, 2026 | Weighted- Average Remaining Contractual Life | Weighted- Average Exercise Price | Number Exercisable at December 31, 2025 | Weighted- Average Exercise Price |
| $0.29-142.08 | 732,142 | 8.9 | $5.11 | 730,267 | $5.12 |
The Black-Scholes option pricing model, used to estimate fair value of the option awards, requires the use of the following assumptions:
Fair value of common stock. The fair value of the common stock is the Company’s closing price per share on the NASDAQ listing at the grant date.
Expected Term. The expected term of options granted represents the period of time that the options are expected to be outstanding. Due to the lack of historical exercise history, the expected term of the Company’s stock options has been determined by calculating the midpoint of the contractual term of the options and the weighted-average vesting period.
Expected Volatility. The expected stock price volatility assumption was determined by examining the historical volatilities for industry peers, as the Company did not have any trading history for the common stock. The Company will continue to analyze the historical stock price volatility and expected term assumption as more historical data for the common stock becomes available.
Risk-Free Interest Rate. The risk-free interest rate assumption is based on the U.S. Treasury instrument whose term was consistent with the expected term of the Company’s stock options.
Dividends. The Company has not paid any cash dividends on common stock since inception and does not anticipate paying any dividends in the foreseeable future. Consequently, an expected dividend yield of zero was used.
The fair value of options granted was estimated using the Black-Scholes valuation model using the following assumptions for the three months ended March 31, 2026:
| Expected volatility | 136% |
|---|---|
| Expected dividend yield | —% |
| Expected term (in years) | 4.92 |
| Risk-free interest rate | 4.0% |
There wasno intrinsic value of the outstanding options at March 31, 2026.
NOTE 7 WARRANTS
Warrants
Warrant transactions during the Three Months ended March 31, 2026 were as follows:
| Shares | Weighted-Average Exercise Price | |
|---|---|---|
| Outstanding at Beginning of Period | 1,863,069 | $9.13 |
| Granted | 11,828,572 | 0.35 |
| Exercised | - | - |
| Forfeited or Cancelled | - | - |
| Outstanding at End of Period | 13,691,641 | 1.55 |
| Warrant Exercisable at Period-End | 13,691,641 | 1.55 |
| Weighted-Average Fair Value of Warrants Granted During the Period | $0.18 |
Information with respect to warrants outstanding and exercisable at March 31, 2026 is as follows:
| Warrants Outstanding · Warrants Exercisable | |||||
|---|---|---|---|---|---|
| Range of Exercise Prices | Number Outstanding at March 31, 2026 | Weighted- Average Remaining Contractual Life | Weighted- Average Exercise Price | Number Exercisable at March 31, 2026 | Weighted- Average Exercise Price |
| $0.35 -$34.00 | 13,691,641 | 1.9 | $1.55 | 13,691,641 | $1.55 |
There wasno intrinsic value of the outstanding warrants at March 31, 2026.
NOTE 8 EARNINGS (LOSS) PER SHARE
Basic earnings per share (“EPS”) is computed by dividing reported earnings available to stockholders by the weighted average shares outstanding. We had net losses for the three months ended March 31, 2026 and 2025 and the effect of including dilutive securities in the earnings per common share would have been anti-dilutive for the purpose of calculating EPS. Accordingly, all options, warrants, and shares potentially convertible into common shares were excluded from the calculation of diluted earnings per share for the periods ended March 31, 2026 and 2025.
| March 31, 2026 | March 31, 2025 | |
|---|---|---|
| Basic EPS | ||
| Net Loss | $(532,831) | $(793,672) |
| Weighted Average Shares | 8,927,360 | 2,808,071 |
| Basic Loss Per Share | $(0.06) | $(0.28) |
For the three months ended March 31, 2026 and 2025, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:
| March 31, 2026 | March 31, 2025 | |
|---|---|---|
| Warrants | 13,691,641 | 1,863,069 |
| Options | 732,142 | 214,819 |
| Total | 14,423,783 | 2,077,888 |
NOTE 9 COMMITMENTS AND CONTINGENCIES
The Company may be involved in certain legal proceedings that arise from time to time in the ordinary course of our business. Except for income tax contingencies, we record accruals for contingencies to the extent that our management concludes that the occurrence is probable and that the related amounts of loss can be reasonably estimated. Management believes the accompanying financial statements include all provisions, of any, for any potential losses. Legal expenses associated with the contingency are expensed as incurred.
Pursuant to certain contracts with Chicony Power Technology Co., Ltd., Shihlin Electric & Engineering Corporation, National Chung Shan Institute of Science and Technology and Chung-Hsin Electric and Machinery Manufacturing Corp., Iveda Taiwan is required to provide after-project services. If Iveda Taiwan fails to provide these after-project services in the future, other parties of the related contract would have recourse. The financial exposure to Iveda Taiwan in the event of failure to provide after- project services in the future as of March 31, 2026 is $361,953.
NOTE 10 SEGMENT INFORMATION
The Company operates and manages its business astwo reportable and operating segments. The Company’s CODM reviews financial information presented and decides how to allocate resources based on net income (loss). Net income (loss) is used for evaluating financial performance.
Significant segment expenses include salaries and payroll, marketing, public company expenses, audit and accounting, consulting, research and development, travel and entertainment, software subscription and other administrative expenses for the US and salaries and payroll, rent, travel and entertainment, and other administrative expenses. The following table presents the significant segment expenses and other segment items regularly reviewed by our CODM.
| Three Months Ended March 31, 2026 · Three Months Ended March 31, 2025 | |||||||
|---|---|---|---|---|---|---|---|
| Consolidated · US · Taiwan · Consolidated · US · Taiwan | |||||||
| Revenues | $1,494,174 | $23,482 | $1,470,692 | $1,474,576 | $238,426 | $1,236,150 | |
| Cost of Goods Sold | 998,966 | 24,186 | 974,780 | 1,186,365 | 183,628 | 1,002,737 | |
| Gross Profit | 495,208 | (704) | 495,912 | 288,211 | 54,798 | 233,413 | |
| 33% | (3% | ) | 34% | 20% | 23% | 19% | |
| Operating Expenses | |||||||
| Salaries and Payroll Expenses | 348,453 | 234,190 | 114,264 | 344,210 | 253,965 | 90,245 | |
| Travel and Entertainment | 65,443 | 54,664 | 10,779 | 142,578 | 129,964 | 12,614 | |
| Marketing | 106,476 | 106,476 | - | 76,255 | 76,255 | - | |
| Public Company expenses | 61,705 | 61,705 | - | 57,076 | 57,076 | - | |
| Audit and Accounting | 90,087 | 90,087 | - | 167,883 | 167,883 | - | |
| Research and Development | 30,000 | 30,000 | - | 33,000 | 33,000 | - | |
| Rent | 37,256 | 24,306 | 12,951 | 35,006 | 22,915 | 12,091 | |
| Other operating expenses | 321,488 | 257,774 | 63,714 | 267,762 | 200,755 | 67,007 | |
| Total Operating Expenses | 1,060,910 | 859,202 | 201,708 | 1,123,770 | 941,813 | 181,957 | |
| Income (Loss) from Operations | (565,702) | (859,908) | 294,204 | (835,559) | (887,015) | 51,456 | |
| Interest Income and Other (Expenses), net | 32,871 | 26,981 | 5,890 | 41,887 | 39,141 | 2,746 | |
| Net loss | $(532,831) | $(832,925) | $300,094 | $(793,672) | $(847,874) | $54,202 | |
Furthermore, due to operations in various geographic locations, we are susceptible to changes in national, regional, and local economic conditions, demographic trends, consumer confidence in the economy, and discretionary spending priorities that may have a material adverse effect on our future operations and results.
We are required to collect certain taxes and fees from customers on behalf of government agencies and remit them back to the applicable governmental agencies on a periodic basis. The taxes and fees are legal assessments to the customer, for which we have a legal obligation to act as a collection agent. Because we do not retain the taxes and fees, we do not include such amounts in revenue. We record a liability when the amounts are collected and relieve the liability when payments are made to the applicable governmental agencies.
The Net Revenues for our significant geographic regions are as follows:
| Net Revenues | ||
|---|---|---|
| For the Three Months ended | For the Three Months ended | |
| March 31, 2026 | March 31, 2025 | |
| United States | $23,482 | $238,426 |
| Republic of China (Taiwan) | $1,470,692 | $1,236,150 |
| Total Consolidated | $1,494,174 | $1,474,576 |
The net assets (liabilities) for our significant geographic regions are as follows:
| Net Assets (Liabilities) | ||
|---|---|---|
| As of | As of | |
| March 31, 2026 | December 31, 2025 | |
| United States | $4,722,729 | $3,918,970 |
| Republic of China (Taiwan) | $1,141,530 | $860,792 |
| Republic of China (Taiwan) [Member] | ||
| Total Consolidated | $5,864,259 | $4,779,762 |
NOTE 11 SUBSEQUENT EVENTS
The Company evaluates subsequent events and transactions that occur after the balance sheet date up to the date that the financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the financial statements were available for issuance are disclosed as subsequent events, while the financial statements are adjusted to reflect any conditions that existed at the balance sheet date.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.